Pharmaceutical availability across levels of care: Evidence from facility surveys in Ghana, Kenya, and Uganda

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Masters, Samuel H ^a   Burstein, Roy ^b   Decenso, Brendan ^c   Moore, Kelsey ^b   Haakenstad, Annie ^b   Ikilezi, Gloria ^d   Achan, Jane ^d   Osei, Ivy ^e   Garshong, Bertha ^e   Kisia, Caroline ^f   Njuguna, Pamela ^f   Babigumira, Joseph ^g   Kumar, Santosh ^h   Hanlon, Michael ^b   Gakidou, Emmanuela ^b  

^a IL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c RTI INTERNATIONAL   (United States)

^d INFECTIOUS DISEASES RESEARCH COLLABORATION   (Uganda)

^e GHANA HEALTH SERVICE   (Ghana)

^f Action Africa Help International   (Kenya)

^g UNIVERSITY OF WASHINGTON   (United States)

^h SAM HOUSTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; ESSENTIAL MEDICINE LIST; GHANA; HEALTH CARE; HEALTH CARE AVAILABILITY; HEALTH CARE NEED; HEALTH CARE SURVEY; HUMAN; KENYA; PHARMACY; UGANDA; WORLD HEALTH ORGANIZATION; HEALTH CARE DELIVERY; HEALTH SERVICE; QUESTIONNAIRE; SUPPLY AND DISTRIBUTION;

ESSENTIAL DRUG;

DRUGS, ESSENTIAL; GHANA; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; KENYA; SURVEYS AND QUESTIONNAIRES; UGANDA;

EID: 84956924634     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114762     Document Type: Article

References (30)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380:2095-2128. doi:10.1016/S0140-6736 (12) 61728-0.
2. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380:2197-2223. doi:10.1016/S0140-6736 (12) 61689-4.
3. Pasquet A, Messou E, Gabillard D, Minga A, Depoulosky A, et al. (2010) Impact of Drug Stock-Outs on Death and Retention to Care among HIV-Infected Patients on Combination Antiretroviral Therapy in Abidjan, Côte d9Ivoire. PLoS ONE 5:e13414. doi:10.1371/journal.pone.0013414.
4. Nabbuye-Sekandi J, Makumbi FE, Kasangaki A, Kizza IB, Tugumisirize J, et al. (2011) Patient satisfaction with services in outpatient clinics at Mulago hospital, Uganda. Int J Qual Health Care 23:516-523. doi:10.1093/intqhc/mzr040.
5. Hanson K, McPake B, Nakamba P, Archard L (2005) Preferences for hospital quality in Zambia: results from a discrete choice experiment. Health Econ 14:687-701. doi:10.1002/hec.959.
6. Mugisha F, Bocar K, Dong H, Chepng9eno G (2004) The two faces of enhancing utilization of healthcare services: determinants of patient initiation and retention in rural Burkina Faso. Bulletin of the World Health Organization 82:572-579. doi:10.1590/S0042-96862004000800006.
7. World Health Organization, Health Action International (2003) Medicine prices: a new approach to measurement. Available: http://apps.who.int/iris/handle/10665/67911. Accessed 2013 May 27.
8. Babar ZUD, Ibrahim MIM, Singh H, Bukahri NI, Creese A (2007) Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia. PLoS Med 4. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1831730/. Accessed 29 May 2013.
9. Cheraghali AM, Idries AM (2009) Availability, affordability, and prescribing pattern of medicines in Sudan. Pharm World Sci 31:209-215. doi:10.1007/s11096-009-9282-3.
10. Mendis S, Fukino K, Cameron A, Laing R, Filipe A Jr, et al. (2007) The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bulletin of the World Health Organization 85:279-288. doi:10.1590/S0042-96862007000400013.
11. Mourik MS van, Cameron A, Ewen M, Laing RO (2010) Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data. BMC Cardiovascular Disorders 10:25. doi:10.1186/1471-2261-10-25.
12. Yang H, Dib HH, Zhu M, Qi G, Zhang X (2010) Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China. Health Policy Plan 25:219-229. doi:10.1093/heapol/czp056.
13. Cameron A, Ewen M, Rossdegnan D, Ball D, Laing R (2009) Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. The Lancet 373:240-249. doi:10.1016/S0140-6736 (08) 61762-6.
14. Bazargani YT, Ewen M, de Boer A, Leufkens HGM, Mantel-Teeuwisse AK (2014) Essential Medicines Are More Available than Other Medicines around the Globe. PLoS ONE 9:e87576. doi:10.1371/journal.pone.0087576.
15. Buabeng KO, Duwiejua M, Matowe LK, Smith F, Enlund H (2008) Availability and Choice of Antimalarials at Medicine Outlets in Ghana: The Question of Access to Effective Medicines for Malaria Control. Clin Pharmacol Ther 84:613-619. doi:10.1038/clpt.2008.130.
16. Kangwana BB, Njogu J, Wasunna B, Kedenge SV, Memusi DN, et al. (2009) Malaria Drug Shortages in Kenya. Am J Trop Med Hyg 80:737-738.
17. Davis B, Ladner J, Sams K, Tekinturhan E, Korte D de, et al. (2013) Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries. Malaria Journal 12:135. doi:10.1186/1475-2875-12-135.
18. Tumwine Y, Kutyabami P, Odoi RA, Kalyango JN (2010) Availability and Expiry of Essential Medicines and Supplies During the "Pull" and "Push" Drug Acquisition Systems in a Rural Ugandan Hospital. Tropical Journal of Pharmaceutical Research 9. Available: http://www.ajol.info/index.php/tjpr/article/view/63555. Accessed 29 May 2013.
19. Laing R, Waning B, Gray A, Ford N, 9t Hoen E (2003) 25 years of the WHO essential medicines lists: progress and challenges. The Lancet 361:1723-1729. doi:10.1016/S0140-6736 (03) 13375-2.
20. World Health Organization (2013) WHO Model Lists of Essential Medicines 18th Edition. Available: http://www.who.int/medicines/publications/essentialmedicines/18th-EML-Final-web-8Jul13.pdf. Accessed 13 July 2013.
21. Ghana National Drugs Program, Ministry of Health (2010) Ghana Essential Medicines List Sixth Edition.
22. Kenya Ministry of Medical Services, Kenya Ministry of Public Health & Sanitation (2010) Kenya Essential Medicines List.
23. Uganda Ministry of Health (2011) Uganda Essential Medicines List.
24. Institute for Health Metrics and Evaluation (IHME) (2013) Access, Bottlenecks, Costs, and Equity: Assessing Health System Performance and Barriers to Care in Ghana. Seattle, WA: IHME.
25. Institute for Health Metrics and Evaluation (IHME) (2014) Health Service Provision in Kenya: Assessing Facility Capacity, Costs of Care, and Patient Perspectives. Seattle, WA: IHME.
26. Institute for Health Metrics and Evaluation (IHME) (2014) Health Service Provision in Uganda: Assessing Facility Capacity, Costs of Care, and Patient Perspectives. Seattle, WA: IHME.
27. StataCorp (2011) Stata Statistical Software: Release 12. College Station, TX: StataCorp LP.
28. Robertson J, Forte G, Trapsida J-M, Hill S (2009) What essential medicines for children are on the shelf? Bulletin of the World Health Organization 87:231-237. doi:10.1590/S0042-96862009000300018.
29. Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ (2005) The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers. PLoS Med 2:e100. doi:10.1371/journal.pmed.0020100.
30. Kaur H, Goodman C, Thompson E, Thompson K-A, Masanja I, et al. (2008) A Nationwide Survey of the Quality of Antimalarials in Retail Outlets in Tanzania. PLoS ONE 3:e3403. doi:10.1371/journal.pone.0003403.